Title: Burbridge MF, et al. S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab. Mol Cancer Ther. 2013 Sep;12(9):1749-62.
1265965-19-2
1265966-31-1
186543-64-6 | LY 344864 racemate | AA01EOAT | MFCD31619294
1138245-21-2 | Mirogabalin besylate | AA01EOG9 | MFCD31631215
95523-13-0 | N-[(4-Aminophenyl)methyl]adenosine | AA01EOLU | MFCD00083216
864731-61-3 | Fluralaner | AA01EOQ8 | MFCD30533410
1630023-00-5 | (2S,3S,4S,5R,6R)-6-((6-(3-(1-naphthoyl)-1H-indol-1-yl)hexyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylicacid | AA01EP08
1411646-44-0 | 6-chloro-1,2,3,4-tetrahydro-N-[2-(4-methyl-1-piperazinyl)ethyl]-9-acridinamine | AA01EPB6
1631074-54-8 | 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide | AA01EPHN
258871-60-2 | 3S-[[4-(2-hydroxyethoxy)phenyl]methyl]-4,10R-dimethyl-13R-pentyl-1-oxa-4-azacyclotridecane-2,5-dione | AA01EPNS
2160555-55-3 | 2,5-dihydro-2-(1-methyl-1-phenylethyl)-5-pentyl-1H-pyrido[4,3-b]indol-1-one | AA01EPU5
1360882-59-2 | 2-amino-N-[(1S,2R,3E)-1-[[(O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-acetamide | AA01EQ3J